YHLO

2021-10-28

Summary:





Recently, another installation of YHLO iModules system with Beckman Coulter Power Express clinical lab automation systems was perfectly completed in the Sixth Hospital of Wuhan, Hubei Province, China. This integrated Total Laboratory Automation (TLA) will boost the efficiency of daily workload in the hospital's laboratory.

Working together to expand the value cooperation of the intelligent laboratory, YHLO and Beckman Coulter strive to create an overall solution that meets the diversified needs of the customers.

Previous: Great inheritance of YHLO iFlash Series, new product being installed

Next: YHLO Joined Hands With Peking University In Molecular Diagnosis

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +